This review focuses on the advancement of the metabolism and agonists of NRs closely related to NAFLD, including PPARs, LXRs, FXRs, REV-ERB, HNF4α, CAR and PXR nuclear receptors. Here, NR1I2 is linked to metabolic dysfunction-associated steatotic liver disease.